<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
The balance between cell cycle progression and apoptosis is important for both surveillance against genomic defects and responses to drugs that arrest the cell cycle. In this report, we show that the level of the human anti-apoptotic protein Mcl-1 is regulated during the cell cycle and peaks at mitosis. Mcl-1 is phosphorylated at two sites in mitosis, Ser64 and Thr92. Phosphorylation of Thr92 by cyclin-dependent kinase 1 (CDK1)-cyclin B1 initiates degradation of Mcl-1 in cells arrested in mitosis by microtubule poisons. Mcl-1 destruction during mitotic arrest requires proteasome activity and is dependent on Cdc20/Fizzy, which mediates recognition of mitotic substrates by the anaphase-promoting complex/cyclosome (APC/C) E3 ubiquitin ligase. Stabilisation of Mcl-1 during mitotic arrest by mutation of either Thr92 or a D-box destruction motif inhibits the induction of apoptosis by microtubule poisons. Thus, phosphorylation of Mcl-1 by CDK1-cyclin B1 and its APC/C(Cdc20)-mediated destruction initiates apoptosis if a cell fails to resolve mitosis. Regulation of apoptosis, therefore, is linked intrinsically to progression through mitosis and is governed by a temporal mechanism that distinguishes between normal mitosis and prolonged mitotic arrest.
2800 Neuroscience, Phosphopeptides, 570, Proteasome Endopeptidase Complex, 571, 1300 Biochemistry, CASPASE 9, Cdc20 Proteins, Molecular Sequence Data, 610, Mitosis, Genetics and Molecular Biology, Apoptosis, Cell Cycle Proteins, ANTIMITOTIC DRUGS, Cell Line, UBIQUITIN LIGASE, Apc3 Subunit, Anaphase-Promoting Complex-Cyclosome, CDC2 Protein Kinase, 1312 Molecular Biology, Serine, CELL-CYCLE, Animals, Humans, Cdc20, Amino Acid Sequence, CANCER-CELLS, Cyclin B1, Phosphorylation, mitosis, ANAPHASE-PROMOTING COMPLEX/CYCLOSOME, apoptosis, 2400 Immunology and Microbiology, Mcl-1, PROTEIN-KINASE, Caspase 9, cyclin-dependent kinase, Proto-Oncogene Proteins c-bcl-2, SPINDLE-ASSEMBLY CHECKPOINT, SURVIVAL, Myeloid Cell Leukemia Sequence 1 Protein, RNA Interference
2800 Neuroscience, Phosphopeptides, 570, Proteasome Endopeptidase Complex, 571, 1300 Biochemistry, CASPASE 9, Cdc20 Proteins, Molecular Sequence Data, 610, Mitosis, Genetics and Molecular Biology, Apoptosis, Cell Cycle Proteins, ANTIMITOTIC DRUGS, Cell Line, UBIQUITIN LIGASE, Apc3 Subunit, Anaphase-Promoting Complex-Cyclosome, CDC2 Protein Kinase, 1312 Molecular Biology, Serine, CELL-CYCLE, Animals, Humans, Cdc20, Amino Acid Sequence, CANCER-CELLS, Cyclin B1, Phosphorylation, mitosis, ANAPHASE-PROMOTING COMPLEX/CYCLOSOME, apoptosis, 2400 Immunology and Microbiology, Mcl-1, PROTEIN-KINASE, Caspase 9, cyclin-dependent kinase, Proto-Oncogene Proteins c-bcl-2, SPINDLE-ASSEMBLY CHECKPOINT, SURVIVAL, Myeloid Cell Leukemia Sequence 1 Protein, RNA Interference
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 302 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |